SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is currently the focus of intense market conversation as investors keenly await its impending earnings report, with community sentiment weighing high expectations for continued AI-driven growth against concerns of a 'priced to perfection' valuation and significant options volatility.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is seeing a significant surge following robust Q4 earnings, which highlighted strong growth in USDC adoption and transaction volumes. This positive report is triggering a notable short squeeze and widespread bullish sentiment, though some investors are cautioning about potential profit-taking and expressing concerns regarding its valuation.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as Warner Bros. Discovery considers a higher bid from Paramount Skydance, putting pressure on Netflix to either counter or exit the contentious acquisition. Shareholders are actively debating if walking away to secure a substantial breakup fee is the better strategic move, freeing the company from potential debt and regulatory hurdles.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is a focal point as investors eagerly await NVIDIA's earnings, hoping a strong report will catalyze a significant move for the AI infrastructure provider, which many believe is undervalued. The community is actively discussing recent strategic partnerships, including a new Enterprise AI Data Platform with VAST Data and NVIDIA, and a major sovereign AI initiative in the Middle East, reinforcing SMCI's critical role in global AI buildouts despite ongoing frustration over its muted short-term price action.

Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.

Larimar Therapeutics Inc

Its Friedreich's ataxia treatment has received FDA Breakthrough Therapy Designation, signaling potential for accelerated approval and exciting the community with its disease-modifying potential. Investors are actively discussing significant analyst price target increases, a high short interest suggesting a potential squeeze, and the possibility of a buyout.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending due to robust earnings that surpassed expectations, paired with an upbeat FY26 outlook for same-store sales and new restaurant expansion, fueling strong bullish sentiment. The community is actively discussing its premium valuation and growth potential, with bulls comparing it favorably to competitors like Chipotle, while bears highlight persistent margin pressures and a high P/E ratio.

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals is trending following its FDA approval for DESMODA (desmopressin acetate) Oral Solution, a key rare disease treatment. While some investors celebrated a "huge move," others are debating if the news was "priced in," noting a mixed initial price reaction and high short interest amidst a stock halt.

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

Workday Inc

Workday is trending after a post-earnings sell-off driven by cautious future subscription revenue guidance, despite beating current EPS and revenue estimates. The community is actively debating if the software stock is undervalued following its strong intraday reversal, with many highlighting its AI strategy and the return of its co-founder.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech is trending after a significant stock drop caused by an anticipated ~30% revenue decline in Q1 2026 due to an "online marketing glitch" and a lack of clear forward guidance. The community is sharply divided, with bulls seeing an oversold opportunity due to strong past performance and buybacks, while bears decry management's transparency and warn of deeper issues.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending following a notable stock decline, igniting community debate around whether AI advancements, like Anthropic's recent acquisition, represent a competitive threat or validate its strategic position as an AI orchestration platform, with many investors anticipating a rebound driven by strong fundamentals and upcoming earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Public Sector Pension Investment Board Increases Holdings in Innoviva, Inc. $INVA

Public Sector Pension Investment Board raised its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 24.0% in the third quarter, according to its most recent 13F filing with the...

Innoviva to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva...

Bayer (BAYRY) Surges 6.0%: Is This an Indication of Further Gains?

Bayer (BAYRY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Innoviva (NASDAQ:INVA) Upgraded to "Strong-Buy" at BTIG Research

BTIG Research raised shares of Innoviva to a "strong-buy" rating in a research note on Tuesday...

Innoviva (INVA) to Release Quarterly Earnings on Wednesday

Innoviva (NASDAQ:INVA) will be releasing its Q4 2025 earnings before the market opens on Wednesday, February 25. (View Earnings Report at...

Denali Advisors LLC Trims Position in Innoviva, Inc. $INVA

Denali Advisors LLC decreased its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 76.8% during the 3rd quarter, according to its most recent disclosure with the Securities...

Innoviva (NASDAQ:INVA) Sets New 52-Week High - Should You Buy?

Innoviva (NASDAQ:INVA) Reaches New 52-Week High - Time to Buy...

New York State Common Retirement Fund Decreases Stock Holdings in Innoviva, Inc. $INVA

New York State Common Retirement Fund lowered its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 74.7% in the 3rd quarter, according to its most recent Form 13F filing with the...

Allianz Asset Management GmbH Has $3.59 Million Holdings in Innoviva, Inc. $INVA

Allianz Asset Management GmbH boosted its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 139.2% in the 3rd quarter, according to the company in its most recent filing with the Securities...

Eli Lilly (LLY) Q4 Earnings and Revenues Beat Estimates

Lilly (LLY) delivered earnings and revenue surprises of +7.88% and +7.95%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Innoviva Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

Ahead of earnings, sentiment is split between blowout AI growth and concerns around macro pressure, positioning, and post-ER volatility. How do you see it playing out?

Current Price	$23.94
Prev Close	$23.42
Open	$23.54
Dividend Yield	0.00%
50-Day Moving Average	$20.64
Beta	0.28
Avg. Volume	630,083.15
PE Ratio	16.80

52-Week High	$24.01
52-Week Low	$16.52
Market Capitalization	$2.5B
EPS (Annual)	$0.3621
Price to Book	1.73
Revenue Per Employee	$2.93M

INVA
Innoviva Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INVA News

INVAInnoviva Inc